Delphine Simon Agathon is a Senior Director and Category Clinician at Pfizer, where they lead clinical development in gene therapy, focusing on AAV-based products. They previously held roles including Clinical Leader at Forenap Pharma and Senior Clinical Project Manager at Genethon and Transgene, overseeing clinical studies in neuromuscular diseases and oncology. Delphine earned a PhD while studying neurodegenerative genetic diseases at IGBMC, where they contributed to multiple key publications. They hold a Licence and Master Degree in Chemistry and Biology and a Postgraduate Degree in Molecular and Cellular Biology from Université de Strasbourg.
Location
Paris, France
Links
This person is not in any teams
This person is not in any offices